Acasti Pharma (ACST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Operating Expenses | 8,034 | 4,121 | 4,031 | 6,146 | 6,255 |
Operating Income | -8,034 | -4,121 | -4,031 | -6,146 | -6,255 |
Interest Expense | 0 | 0 | -5,742 | 5,977 | 0 |
Other Income | 1,888 | -545 | 14,903 | 0 | -14,903 |
Pre-tax Income | -6,146 | -4,666 | 16,614 | -12,123 | -21,158 |
Net Income Continuous | -6,146 | -4,666 | 16,614 | -12,123 | -21,158 |
Net Income | $-6,146 | $-4,666 | $16,614 | $-12,123 | $-21,158 |
EPS Basic Total Ops | -3.12 | -2.40 | 9.60 | -6.72 | -12.00 |
EPS Basic Continuous Ops | -3.10 | -2.47 | 9.85 | -6.71 | -12.22 |
EPS Diluted Total Ops | -3.12 | -2.40 | 9.60 | -6.72 | -12.00 |
EPS Diluted Continuous Ops | -3.10 | -2.47 | 9.85 | -6.71 | -12.22 |
EBITDA(a) | $-7,659 | $-3,573 | $-3,431 | $-5,550 | $-5,701 |